Supportive care intervention improves function and reduces fatigue in older lung cancer patients

Improving efficacy and toxicity reporting - and treatment insights from an oncologist patient

CURB phase II trial: Tumour burden predicts survival after SBRT in NSCLC oligoprogression

WCLC 2025: Latest in EGFR positive NSCLC

Dose escalation of RG6344 demonstrates safety and promising activity in BRAF V600E solid tumours

Treatment management of favourable risk and very favourable risk patients

Phase I/II trial shows promising activity of invikafusp alfa in PD-1–resistant GI cancers

Nivolumab plus ipilimumab improves survival results in MSI-H/dMMR metastatic colorectal cancer

Key insights from head and neck research at ASCO 2025

Understanding genetic aberrations in lung cancer treatment: NTRK, RET, NRG

ASCO 2025: Developments in the treatment of soft tissue sarcoma

Key updates on breast cancer treatments from ASCO 2025